Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Carroll

Showing results (851-860 of 1,434) with videos related to

Pageof 144
Sort By:
BJU International|January 18, 2007
Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imagingFergus V Coakley, Irene Chen, Aliya Qayyum, et al.
Journal of Natural Products|June 23, 2007
Endiandrin A, a potent glucocorticoid receptor binder isolated from the Australian plant Endiandra anthropophagorumRohan A Davis, Anthony R Carroll, Sandra Duffy, et al.
Journal of Natural Products|August 23, 2023
Cyclotheonellazoles D-I, Potent Elastase Inhibitory Thiazole-Containing Cyclic Peptides from <i>Theonella</i> sp. (2131)Darren C Holland, Wayne A Schroder, Mark J Calcott, et al.
Radiologia Brasileira|November 1, 2017
Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancerMichael S Leapman, Zhen J Wang, Spencer C Behr, et al.
NMR in Biomedicine|September 30, 2017
Characterization and stratification of prostate lesions based on comprehensive multiparametric MRI using detailed whole-mount histopathology as a reference standardOlga Starobinets, Jeffry P Simko, Kyle Kuchinsky, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1989
Neurovisual outcome following proton radiation therapyI L Habrand, M Austin-Seymour, S Birnbaum, et al.
Pain Research and Treatment|February 17, 2016
Factors Associated with Opioid Use in a Cohort of Patients Presenting for SurgeryJennifer M Hah, Yasamin Sharifzadeh, Bing M Wang, et al.
Urologic Oncology|July 19, 2022
Medium Term Outcomes of Focal Cryoablation for Intermediate and High Risk Prostate Cancer: MRI and PSA are Not Predictive of Residual or Recurrent DiseaseAvi Baskin, Leslie Bernal Charondo, Ashwin Balakrishnan, et al.
European Urology|October 20, 2023
Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate CancerAnnika Herlemann, Janet E Cowan, Samuel L Washington, et al.
The Journal of Urology|December 2, 2021
Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate CancerPeter E Lonergan, Samuel L Washington, Janet E Cowan, et al.
Pageof 144

Showing results (851-860 of 1,434) with videos related to

Sort By:
Pageof 144
BJU International|January 18, 2007
Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imagingFergus V Coakley, Irene Chen, Aliya Qayyum, et al.
Journal of Natural Products|June 23, 2007
Endiandrin A, a potent glucocorticoid receptor binder isolated from the Australian plant Endiandra anthropophagorumRohan A Davis, Anthony R Carroll, Sandra Duffy, et al.
Journal of Natural Products|August 23, 2023
Cyclotheonellazoles D-I, Potent Elastase Inhibitory Thiazole-Containing Cyclic Peptides from <i>Theonella</i> sp. (2131)Darren C Holland, Wayne A Schroder, Mark J Calcott, et al.
Radiologia Brasileira|November 1, 2017
Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancerMichael S Leapman, Zhen J Wang, Spencer C Behr, et al.
NMR in Biomedicine|September 30, 2017
Characterization and stratification of prostate lesions based on comprehensive multiparametric MRI using detailed whole-mount histopathology as a reference standardOlga Starobinets, Jeffry P Simko, Kyle Kuchinsky, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1989
Neurovisual outcome following proton radiation therapyI L Habrand, M Austin-Seymour, S Birnbaum, et al.
Pain Research and Treatment|February 17, 2016
Factors Associated with Opioid Use in a Cohort of Patients Presenting for SurgeryJennifer M Hah, Yasamin Sharifzadeh, Bing M Wang, et al.
Urologic Oncology|July 19, 2022
Medium Term Outcomes of Focal Cryoablation for Intermediate and High Risk Prostate Cancer: MRI and PSA are Not Predictive of Residual or Recurrent DiseaseAvi Baskin, Leslie Bernal Charondo, Ashwin Balakrishnan, et al.
European Urology|October 20, 2023
Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate CancerAnnika Herlemann, Janet E Cowan, Samuel L Washington, et al.
The Journal of Urology|December 2, 2021
Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate CancerPeter E Lonergan, Samuel L Washington, Janet E Cowan, et al.
Pageof 144